209 related articles for article (PubMed ID: 33155691)
1. Skeletal muscle magnetic resonance imaging in Pompe disease.
Díaz-Manera J; Walter G; Straub V
Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor imaging reveals changes in non-fat infiltrated muscles in late onset Pompe disease.
Rehmann R; Froeling M; Rohm M; Forsting J; Kley RA; Schmidt-Wilcke T; Karabul N; Meyer-Frießem CH; Vollert J; Tegenthoff M; Vorgerd M; Schlaffke L
Muscle Nerve; 2020 Oct; 62(4):541-549. PubMed ID: 32654203
[TBL] [Abstract][Full Text] [Related]
4. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
[TBL] [Abstract][Full Text] [Related]
5. 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease.
Plöckinger U; Prasad V; Ziagaki A; Tiling N; Poellinger A
Hum Genomics; 2018 Mar; 12(1):14. PubMed ID: 29523196
[TBL] [Abstract][Full Text] [Related]
6. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
[TBL] [Abstract][Full Text] [Related]
7. Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
Peng SS; Hwu WL; Lee NC; Tsai FJ; Tsai WH; Chien YH
Orphanet J Rare Dis; 2016 May; 11(1):63. PubMed ID: 27183828
[TBL] [Abstract][Full Text] [Related]
8. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
[TBL] [Abstract][Full Text] [Related]
9. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.
Musumeci O; Marino S; Granata F; Morabito R; Bonanno L; Brizzi T; Lo Buono V; Corallo F; Longo M; Toscano A
Eur J Neurol; 2019 Mar; 26(3):442-e35. PubMed ID: 30312517
[TBL] [Abstract][Full Text] [Related]
12. Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD).
Ripolone M; Violano R; Ronchi D; Mondello S; Nascimbeni A; Colombo I; Fagiolari G; Bordoni A; Fortunato F; Lucchini V; Saredi S; Filosto M; Musumeci O; Tonin P; Mongini T; Previtali S; Morandi L; Angelini C; Mora M; Sandri M; Sciacco M; Toscano A; Comi GP; Moggio M
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):449-462. PubMed ID: 28574618
[TBL] [Abstract][Full Text] [Related]
13. Fasciculations in Late-Onset Pompe Disease: A Sign of Motor Neuron Involvement?
Monforte M; Servidei S; Ricci E; Tasca G
Can J Neurol Sci; 2017 Jul; 44(4):463-464. PubMed ID: 28143629
[No Abstract] [Full Text] [Related]
14. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
[TBL] [Abstract][Full Text] [Related]
15. Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
Alejaldre A; Díaz-Manera J; Ravaglia S; Tibaldi EC; D'Amore F; Morís G; Muelas N; Vílchez JJ; García-Medina A; Usón M; Martínez García FA; Illa I; Pichiecchio A
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S148-54. PubMed ID: 22980766
[TBL] [Abstract][Full Text] [Related]
16. Bent spine syndrome as the initial symptom of late-onset Pompe disease.
Taisne N; Desnuelle C; Juntas Morales R; Ferrer Monasterio X; Sacconi S; Duval F; Sole G; Flipo RM; Lacour A; Vermersch P; Cardon T
Muscle Nerve; 2017 Jul; 56(1):167-170. PubMed ID: 27862019
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes.
Pichiecchio A; Rossi M; Cinnante C; Colafati GS; De Icco R; Parini R; Menni F; Furlan F; Burlina A; Sacchini M; Donati MA; Fecarotta S; Casa RD; Deodato F; Taurisano R; Di Rocco M
Muscle Nerve; 2017 Jun; 55(6):841-848. PubMed ID: 27668838
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients.
Carlier PG; Azzabou N; de Sousa PL; Hicks A; Boisserie JM; Amadon A; Carlier RY; Wary C; Orlikowski D; Laforêt P
J Inherit Metab Dis; 2015 May; 38(3):565-72. PubMed ID: 25749708
[TBL] [Abstract][Full Text] [Related]
19. Treatment Dilemma in Children with Late-Onset Pompe Disease.
Faraguna MC; Crescitelli V; Fornari A; Barzaghi S; Savasta S; Foiadelli T; Veraldi D; Paoletti M; Pichiecchio A; Gasperini S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833288
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy.
Korpela MP; Paetau A; Löfberg MI; Timonen MH; Lamminen AE; Kiuru-Enari SM
Muscle Nerve; 2009 Jul; 40(1):143-8. PubMed ID: 19472353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
